Atara Biotherapeutics (ATRA) Retained Earnings (2013 - 2026)
Atara Biotherapeutics (ATRA) posted Retained Earnings of -$2.0 billion for Q1 2026, down 202601100.0% on a QoQ basis from $1000.0 in Q4 2025, and little changed year-over-year from -$2.0 billion in Q1 2025.
Atara Biotherapeutics (ATRA) Retained Earnings (2013 - 2026) Analysis & Trends
Atara Biotherapeutics' Retained Earnings history runs 14 years deep, the most recent figure standing at -$2.0 billion for Q1 2026.
- Quarterly Retained Earnings changed 0.47% year-over-year to -$2.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.0 billion (changed 0.47% YoY) and the FY2025 annual result came in at $1000.0, down 87.5% from the prior year.
- Retained Earnings was -$2.0 billion for Q1 2026 at Atara Biotherapeutics, down from $1000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $22000.0 in Q3 2024 and bottomed at -$2.0 billion in Q1 2026.
- A 5-year average of -$921.4 million and a median of -$768.2 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings slumped 6743650.0% — and 2024, when it soared 103.85%.
- Atara Biotherapeutics' Retained Earnings stood at -$2.1 million in 2022, then sank by 95166.09% to -$2.0 billion in 2023, then soared by 100.0% to $8000.0 in 2024, then sank by 87.5% to $1000.0 in 2025, then slumped by 202601100.0% to -$2.0 billion in 2026.
- Business Quant data shows ATRA's Retained Earnings at -$2.0 billion in Q1 2026, $1000.0 in Q4 2025, and $2000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -27.89 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -279.01 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 12.91 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -622,000.00 |
| 10 | Atara Biotherapeutics | 110.04 Mn | 101.68 Mn | 392,000.00 | -2.03 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.03 Bn |
| Dec 31, 2025 | 1,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Mar 31, 2025 | -2.02 Bn |
| Dec 31, 2024 | 8,000.00 |
| Sep 30, 2024 | 22,000.00 |
| Jun 30, 2024 | -2.02 Bn |
| Mar 31, 2024 | -2.00 Bn |
| Dec 31, 2023 | -1.97 Bn |
| Sep 30, 2023 | -571,000.00 |
| Jun 30, 2023 | -933,000.00 |
| Mar 31, 2023 | -1.24 Mn |
| Dec 31, 2022 | -2.07 Mn |
| Sep 30, 2022 | -1.62 Bn |
| Jun 30, 2022 | -1.53 Bn |
| Mar 31, 2022 | -1.55 Bn |
| Dec 31, 2021 | -368,000.00 |
| Sep 30, 2021 | 24,000.00 |
| Jun 30, 2021 | -1.29 Bn |
| Mar 31, 2021 | 161,000.00 |